topotecan has been researched along with Cancer of the Retina in 94 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (7.45) | 29.6817 |
2010's | 70 (74.47) | 24.3611 |
2020's | 17 (18.09) | 2.80 |
Authors | Studies |
---|---|
Abramson, DH; Francis, JH; Gobin, YP | 1 |
Abramson, DH; Cancela, B; Chantada, G; Clausse, M; Del Río, M; Del Sole, MJ; Francis, JH; Lamas, G; Lubieniecki, F; Nejamkin, P; Schaiquevich, P | 1 |
Abramson, DH; Antal, Z; Dunkel, IJ; Francis, JH; Friedman, DN; Gobin, YP; Marathe, PH | 1 |
Abramson, DH; Asprea, M; Chantada, G; Fandiño, A; Francis, JH; Lagomarsino, E; Opezzo, J; Requejo, F; Sampor, C; Schaiquevich, P; Vater, A | 1 |
Jabbour, P; Leahey, AM; Selzer, EB; Shields, CL; Welch, RJ | 1 |
Akyüz, C; Kiratli, H; Koç, I; Öztürk, E; Varan, A | 1 |
Ancona-Lezama, D; Baldassari, MP; Dalvin, LA; Das, S; Hammoud, B; Jabbour, P; Lim, LS; Ramesh, S; Shields, CL; Shivashankar, K; Sweid, A; Texakalidis, P; Tjoumakaris, S; Weinberg, JH; Xu, V | 1 |
Abramson, DH; Brodie, SE; Francis, JH; Muca, E; Nadelmann, J | 1 |
Goyal, P; Kochhar, S; Narang, S; Pandey, AK; Sindhu, M | 1 |
Li, X; Lu, S; Ma, J; Tanumiharjo, S; Xing, Y; Yu, X | 1 |
Daniels, AB; Friedman, DL; Froehler, MT; Zheng, Y | 1 |
Borri, M; De Francesco, S; Hadjistilianou, T; Stacey, AW | 1 |
Aghajanpour, L; Amoli, FA; Atyabi, F; Delrish, E; Dinarvand, R; Ghassemi, F; Jabbarvand, M; Lashay, A; Soleimani, M | 1 |
Brennan, RC; King, BA; Sahr, N; Sykes, A; Wilson, MW | 1 |
Acosta, G; Fiani, B; Haynes, M; Nikolaidis, D; Rose, A; Runnels, J; Wong, A | 1 |
Abramson, DH; Bogan, CM; Boyd, KL; Bridges, TM; Calcutt, MW; Chen, SC; Daniels, AB; Francis, JH; Friedman, DL; Hsieh, T; Kaczmarek, JV; Liao, A; Lindsley, CW; Nadelmann, JB; Pierce, JM; Richmond, A | 1 |
Kıratlı, H; Koç, İ; Lotfisadigh, S; Taylan Şekeroğlu, H | 1 |
Cocarta, AI; Dunovska, K; Feriancikova, B; Hobzova, R; Hrabeta, J; Kodetova, M; Pochop, P; Sirc, J; Svojgr, K; Uhlik, J | 1 |
Aggarwal, V; Dhami, A; Maitray, A; Munusamy, S; Ramamurthy, S; Ravikumar, R; Rishi, P; Sharma, M; Sharma, T | 1 |
Abramson, DH; Brodie, SE; Francis, JH; Gobin, YP; Iyer, S | 1 |
Bramuglia, GF; Carcaboso, AM; Castillo-Ecija, H; Chantada, GL; Cuadrado-Vilanova, M; Mora, J; Olaciregui, NG; Opezzo, JAW; Paco, S; Pascual-Pasto, G; Restrepo-Perdomo, CA; Rivero, EM; Schaiquevich, P; Suñol, M; Torrebadell, M; Vila-Ubach, M | 1 |
Bagheri, N; Corrales-Medina, FF; Harbour, JW; Paez-Escamilla, M; Teira, LE | 1 |
Abramson, DH; Berry, JL; Cassoux, N; Francis, JH; Frenkel, S; Hadjistilianou, D; Ji, X; Munier, FL; Schefler, AC; Shields, CL; Teixeira, LF | 1 |
Beck-Popovic, M; Gaillard, MC; Hadjistilianou, D; Maeder, P; Munier, FL; Puccinelli, F; Stathopoulos, C | 1 |
Harbour, JW; Paez-Escamilla, M | 1 |
Gaillard, MC; Munier, FL; Stathopoulos, C | 1 |
Ceciliano, A; Chantada, GL; Fandiño, A; Funes, S; Lagomarsino, E; Manzitti, J; Neira, P; Peralta, L; Sampor, C; Schaiquevich, P; Sgroi, M; Villasante, F | 1 |
Abramson, DH; Brodie, SE; Dunkel, IJ; Francis, JH; Gobin, YP; Levin, A; Mauguen, A; Mondesire-Crump, I; Rowlands, MA | 1 |
Honavar, SG; Mulay, K; Rao, R; Reddy, VAP | 1 |
Ancona-Lezama, D; Dalvin, LA; Jabbour, P; Lucio-Alvarez, JA; Masoomian, B; Shields, CL | 1 |
Meng, B; Qu, W; Wang, S; Yu, Y | 1 |
Bosaleh, A; Chantada, G; Deu, A; Fandiño, A; Requejo, F; Rodriguez, A; Sampor, C; Schaiquevich, P; Sgroi, M; Zugbi, S | 1 |
Ancona-Lezama, D; Dalvin, LA; Jabbour, P; Lucio-Alvarez, JA; Shields, CL | 1 |
Beck-Popovic, M; Gaillard, MC; Moulin, A; Munier, FL; Puccinelli, F; Stathopoulos, C | 1 |
Guo, L; Han, M; Li, J; Song, D; Wang, C; Wang, L; Wang, Z; Wu, C; Yang, Y; Zhao, J | 1 |
Aroonroch, R; Boontawon, T; Chaitankar, V; Chittavanich, P; Hongeng, S; Jinawath, N; Kaewkhaw, R; Rojanaporn, D; Saengwimol, D; Thammachote, W | 1 |
Khetan, V; Sharma, M | 1 |
Honavar, SG; Rao, R; Sthapit, PR | 1 |
Abramson, DH; Brodie, S; Francis, JH; Gobin, YP; Levin, AM; McFadden, M | 1 |
Blair, M; Kotlyar, B; Shapiro, M | 1 |
Camp, DA; Lally, SE; Shields, CL | 1 |
Kapoor, S | 1 |
Chan, HS; Dimaras, H; Gallie, BL; Halliday, W; Héon, E; Yousef, YA | 1 |
Buitrago, E; Ceciliano, A; Chantada, GL; Fandino, A; Lucena, E; Romero, L; Sampor, C; Schaiquevich, P; Taich, P; Villasante, F | 1 |
Abramson, DH; Brodie, SE; Dunkel, IJ; Francis, JH; Gobin, YP; Marr, BP; Riedel, ER | 1 |
Arepalli, SA; Caywood, EH; Jabbour, P; Lally, SE; Manjandavida, FP; Pieretti, G; Shields, CL; Shields, JA | 1 |
Ghadimi, H; Ghassemi, F; Khodabandeh, A; Roohipoor, R; Shields, CL | 1 |
Maidana, DE; Pellegrini, M; Shields, CL; Shields, JA | 1 |
Bramuglia, G; Buitrago, E; Carcaboso, AM; Chantada, GL; Opezzo, J; Schaiquevich, P; Taich, P | 1 |
Palanivelu, MS; Ramanjulu, R | 1 |
Ghassemi, F; Khodabande, A; Shields, CL | 1 |
Brennan, R; Kaste, SC; Orr, B; Tse, BC; Wilson, MW | 1 |
Belmar, Á; Ossandón, D; Pérez, V; Shields, CL; Varas, M; Zanolli, M; Zúñiga, P | 1 |
Lawson, BM; Saktanasate, J; Say, EA; Shields, CL | 1 |
Astudillo, PP; Chan, HS; Durairaj, P; Gallie, BL; Héon, E | 1 |
Dolz-Marco, R; Ferenczy, SR; Hasanreisoglu, M; Shields, CL; Shields, JA | 1 |
Abramson, DH; Francis, JH; Kellick, MG; Marr, BP; Schaiquevich, P | 1 |
Cao, C; Jabbour, PM; Pointdujour-Lim, R; Say, EA; Shields, CL; Shields, JA | 1 |
Bansal, N; Koundanya, V; Ramamurthy, S; Ravikumar, R; Rishi, P; Saravanan, M; Sharma, T | 1 |
Bertelli, E; Bracco, S; Cioni, S; De Francesco, S; Galluzzi, P; Gennari, P; Guglielmucci, D; Hadjistilianou, T; Leonini, S; Romano, DG; Tarantino, F; Vallone, IM; Venturi, C | 1 |
Bracco, S; De Francesco, S; Galluzzi, P; Hadjistilianou, T; Menicacci, F; Motolese, E | 1 |
Abruzzo, TA; Augsburger, JJ; Corrêa, ZM; Geller, JI; Lane, A; Michaels, ST | 1 |
Beggache, M; Douglass, AM; Say, EA; Shields, CL; Shields, JA | 1 |
Deebajah, R; Hajja, Y; Jaradat, I; Mehyar, M; Nawaiseh, I; Sultan, I; Yousef, YA | 1 |
Abramson, DH; Brodie, SE; Dunkel, IJ; Fabius, AW; Francis, JH; Gobin, YP; Marr, BP; Mondesire-Crump, I | 1 |
Hasanreisoglu, M; Iyer, PG; Jabbour, P; Lally, SE; Say, EA; Shields, CL; Shields, JA | 1 |
Alset, AE; Caywood, E; Jabbour, P; Say, EA; Shields, CL; Shields, JA | 1 |
Fuller, DG; Jabbour, PM; Khoo, CT; Magan, T; Shields, CL | 1 |
Abramson, DH; Chantada, GL; Fabius, AW; Francis, JH; Schaiquevich, P | 1 |
Abramson, DH; Brodie, SE; Francis, JH; Marr, B; Mondesire-Crump, I; Zabor, EC | 1 |
Abramson, DH; Francis, JH; Iyer, S; Karl, MD; Marr, B | 1 |
Beck-Popovic, M; Fabian, ID; Gaillard, MC; Munier, FL; Puccinelli, F | 1 |
Chan, H; Gallie, BL; Halliday, W; Hèon, E; Shaikh, F; Soliman, SE | 1 |
Budning, A; Chan, HS; Dai, S; Dimaras, H; Doyle, J; Drake, J; Gallie, BL; Halliday, W; Héon, E | 1 |
Abramson, DH; Bramuglia, GF; Carcaboso, AM; Chantada, GL; de Davila, MT; Fandino, AC; Guitter, MR; Lagomarsino, E; Manzitti, J; Rose, AB | 1 |
Dalgard, CL; deNiro, JE; Gonzalez, M; O'Brien, JM | 1 |
Abramson, DH; Brodie, SE; Dunkel, IJ; Gobin, YP; Marr, B | 2 |
Abramson, DH; Bramuglia, GF; Buitrago, E; Chantada, G; Fandiño, A; Höcht, C; Navo, E; Schaiquevich, P | 1 |
Carcaboso, AM; Dyer, MA; Egorin, M; Federico, S; Nemeth, KM; Schaiquevich, P; Shen, Y; Stewart, C; Zhang, J | 1 |
Babyn, P; Chan, HS; Dimaras, H; Doyle, J; Gallie, BL; Halliday, W; Héon, E; Paton, KE; Strahlendorf, C | 1 |
Chan, HS; Dimaras, H; Gallie, BL; Héon, E; Mallipatna, AC | 1 |
Abramson, DH; Brodie, SE; Dunkel, IJ; Gobin, YP; Hung, C; Marr, BP | 1 |
Billups, CA; Brennan, R; Free, TM; Given, V; Haik, BG; Helton, K; McCarville, MB; Merchant, TE; Qaddoumi, I; Rodriguez-Galindo, C; Stewart, CF; Tagen, M; Wilson, MW; Wu, J | 1 |
Abramson, DH; Brodie, SE; Dunkel, I; Gobin, YP; Marr, BP; Palioura, S | 1 |
Darsova, D; Klapkova, E; Kodetova, D; Lestak, J; Malis, J; Pochop, P; Tesfaye, H; Uhlik, J; Vajner, L | 1 |
Abramson, DH; Brodie, SE; Dunkel, IJ; Gobin, YP; Marr, BP | 1 |
Ceciliano, A; Chantada, GL; Dominguez, J; Fandino, AC; Millan, N; Schaiquevich, P; Taich, P; Villasante, F | 1 |
Liu, W; Shan, BE; Yuan, NF; Zhang, M | 1 |
Asprea, M; Bramuglia, GF; Buitrago, E; Chantada, GL; Croxatto, JO; Del Sole, MJ; Fandino, A; Schaiquevich, P; Torbidoni, A | 1 |
Casak, SJ; Chantada, GL; Fandiño, AC; Manzitti, J; Mato, G; Schvartzman, E | 1 |
Dyer, MA; Egorin, M; Gray, JK; Laurie, NA; Leggas, M; Relling, M; Stewart, C; Zhang, J | 1 |
Abramson, DH; Bramuglia, GF; Carcaboso, AM; Chantada, GL; Chiappetta, DA; de Davila, MT; Fandiño, AC; Rubio, MC | 1 |
Dalgard, C; Edelhauser, HF; Grossniklaus, HE; Lee, L; O'Brien, JM; Tsui, JY; Van Quill, KR | 1 |
4 review(s) available for topotecan and Cancer of the Retina
Article | Year |
---|---|
The role for intra-arterial chemotherapy for refractory retinoblastoma: a systematic review.
Topics: Antineoplastic Agents; Bronchial Spasm; Carboplatin; Drug Resistance, Neoplasm; Edema; Eyelashes; Febrile Neutropenia; Humans; Infusions, Intra-Arterial; Melphalan; Methotrexate; Nausea; Retinal Neoplasms; Retinoblastoma; Salvage Therapy; Topotecan; Vitreous Hemorrhage; Vomiting | 2021 |
Ocular pharmacology of topotecan and its activity in retinoblastoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Routes; Humans; Intravitreal Injections; Retinal Neoplasms; Retinoblastoma; Tissue Distribution; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured; Vitreous Body | 2014 |
Properties and clinical utility of topotecan fluorescence: uses for retinoblastoma.
Topics: Fluorescein Angiography; Fundus Oculi; Humans; Intravitreal Injections; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Topotecan; Vitreous Body | 2015 |
OCULAR PHARMACOLOGY OF CHEMOTHERAPY FOR RETINOBLASTOMA.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Infusions, Intra-Arterial; Injections, Intraocular; Melphalan; Retinal Neoplasms; Retinoblastoma; Topotecan | 2017 |
4 trial(s) available for topotecan and Cancer of the Retina
Article | Year |
---|---|
Chemoreduction with topotecan and vincristine: Quantifying tumor response in bilateral retinoblastoma patients.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Infant; Male; Retinal Neoplasms; Retinoblastoma; Topotecan; Treatment Outcome; Tumor Burden; Vincristine | 2021 |
A phase I study of periocular topotecan in children with intraocular retinoblastoma.
Topics: Antineoplastic Agents; Area Under Curve; Child, Preschool; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Eye Enucleation; Humans; Magnetic Resonance Imaging; Maximum Tolerated Dose; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Topotecan | 2009 |
Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Electroretinography; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Infant; Infusions, Intra-Arterial; Male; Melphalan; Ophthalmic Artery; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Topotecan; Treatment Outcome; Visual Acuity | 2010 |
Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Female; Granulocyte Colony-Stimulating Factor; Humans; Infant; Male; Neutropenia; Retinal Neoplasms; Retinoblastoma; Survival Rate; Thrombocytopenia; Topoisomerase I Inhibitors; Topotecan; Vincristine | 2012 |
86 other study(ies) available for topotecan and Cancer of the Retina
Article | Year |
---|---|
Orbital Retinoblastoma Treated with Intra-arterial Chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carboplatin; Child, Preschool; Drug Therapy, Combination; Humans; Infusions, Intra-Arterial; Magnetic Resonance Imaging; Male; Melphalan; Ophthalmic Artery; Orbital Neoplasms; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Topotecan | 2021 |
Ocular and systemic toxicity of high-dose intravitreal topotecan in rabbits: Implications for retinoblastoma treatment.
Topics: Animals; Intravitreal Injections; Rabbits; Retinal Neoplasms; Retinoblastoma; Topotecan; Vitreous Body | 2022 |
Biochemical measures of ovarian function in female survivors of retinoblastoma treated with intra-arterial melphalan: an initial report.
Topics: Carboplatin; Child; Electroretinography; Female; Humans; Infant; Infusions, Intra-Arterial; Melphalan; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survivors; Topotecan; Treatment Outcome | 2022 |
Pharmacokinetics of Orbital Topotecan After Ophthalmic Artery Chemosurgery and Intravenous Infusion in the Swine Model.
Topics: Animals; Infusions, Intravenous; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Swine; Topotecan | 2023 |
Management of retinoblastoma in older children (>5 years) using intra-arterial chemotherapy: Comparison of outcomes to prechemotherapy and intravenous chemotherapy eras.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carboplatin; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Intravitreal Injections; Male; Melphalan; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome; Young Adult | 2019 |
Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma.
Topics: Antineoplastic Agents, Alkylating; Child, Preschool; Drug Therapy, Combination; Eye Diseases; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Intravitreal Injections; Kaplan-Meier Estimate; Male; Melphalan; Neoplasm Seeding; Proportional Hazards Models; Retinal Diseases; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome; Vitreous Body | 2020 |
Intra-Arterial Chemotherapy for Retinoblastoma in Infants ≤10 kg: 74 Treated Eyes with 222 IAC Sessions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Infant; Infusions, Intra-Arterial; Male; Melphalan; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan; Treatment Outcome | 2020 |
Is intravitreal topotecan toxic to retinal function?
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Electroretinography; Female; Follow-Up Studies; Humans; Infant; Intravitreal Injections; Male; Melphalan; Retina; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topoisomerase I Inhibitors; Topotecan | 2021 |
Adverse drug reaction after intravitreal injection of topotecan.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug-Related Side Effects and Adverse Reactions; Humans; Intravitreal Injections; Retinal Neoplasms; Retinoblastoma; Topotecan | 2020 |
Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma.
Topics: Chemotherapy, Adjuvant; Child; Child, Preschool; Follow-Up Studies; Humans; Infant; Intravitreal Injections; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Topotecan; Treatment Outcome; Visual Acuity; Vitrectomy; Vitreous Body | 2020 |
Intra-arterial Chemotherapy as Primary Treatment for Cavitary Retinoblastoma: Excellent Response in Eight Tumors.
Topics: Antineoplastic Agents; Carboplatin; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Infant; Infusions, Intra-Arterial; Male; Melphalan; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Time Factors; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome; Ultrasonography | 2021 |
The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy.
Topics: Antineoplastic Agents, Alkylating; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Infant; Injections, Intra-Arterial; Male; Melphalan; Prospective Studies; Retina; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome | 2021 |
Efficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma.
Topics: Animals; Antineoplastic Agents; Calorimetry, Differential Scanning; Chitosan; Drug Carriers; Flow Cytometry; Humans; Intravitreal Injections; Male; Nanoparticles; Neoplasm Transplantation; Particle Size; Rats; Rats, Wistar; Retinal Neoplasms; Retinoblastoma; Spectrometry, X-Ray Emission; Spectroscopy, Fourier Transform Infrared; Topoisomerase I Inhibitors; Topotecan; Transplantation, Heterologous; Treatment Outcome; Tumor Cells, Cultured; X-Ray Diffraction | 2021 |
Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study.
Topics: Animals; Antineoplastic Agents, Alkylating; Humans; Intravitreal Injections; Melphalan; Neoplasm Seeding; Rabbits; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan; Vitreous Body | 2022 |
Management of cataracts secondary to intravitreal chemotherapy injections for retinoblastoma seeding.
Topics: Antineoplastic Agents, Alkylating; Cataract; Child; Child, Preschool; Humans; Infant; Intravitreal Injections; Melphalan; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan; Vitreous Body | 2022 |
Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model.
Topics: Animals; Hydrogels; Rabbits; Retinal Neoplasms; Retinoblastoma; Topotecan; Vitreous Body | 2021 |
Intra-arterial chemotherapy for retinoblastoma: Two-year results from tertiary eye-care center in India.
Topics: Antineoplastic Agents, Alkylating; Child, Preschool; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; India; Infant; Injections, Intra-Arterial; Male; Melphalan; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Time Factors; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome; Ultrasonography | 2017 |
Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Cohort Studies; Disease-Free Survival; Electroretinography; Female; Humans; Infusions, Intra-Arterial; Intravitreal Injections; Kaplan-Meier Estimate; Male; Melphalan; Neoplasm Seeding; Ophthalmic Artery; Retina; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan; Vitreous Body | 2017 |
Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Blood-Retinal Barrier; Humans; Mice, Nude; Pantoprazole; Rabbits; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Topotecan; Vitreous Body; Xenograft Model Antitumor Assays | 2017 |
Intracameral Topotecan Hydrochloride for Anterior Chamber Seeding of Retinoblastoma.
Topics: Anterior Chamber; Female; Humans; Infant; Injections, Intraocular; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Topotecan; Ultrasonography | 2017 |
Risk of Extraocular Extension in Eyes With Retinoblastoma Receiving Intravitreous Chemotherapy.
Topics: Antineoplastic Agents; Child, Preschool; Cryotherapy; Female; Humans; Infant; Intravitreal Injections; Male; Melphalan; Methotrexate; Microscopy, Acoustic; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Risk Factors; Topotecan | 2017 |
Successful conservative treatment of massive choroidal relapse in 2 retinoblastoma patients monitored by ultrasound biomicroscopy and/or spectral domain optic coherence tomography.
Topics: Antineoplastic Combined Chemotherapy Protocols; Choroid Neoplasms; Conservative Treatment; Fatal Outcome; Female; Fluorescein Angiography; Humans; Infant; Infusions, Intra-Arterial; Magnetic Resonance Imaging; Melphalan; Microscopy, Acoustic; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Tomography, Optical Coherence; Topotecan | 2018 |
Anterior Chamber Chemotherapy in Retinoblastoma-Necessary But Not Sufficient for Aqueous Seeding Control-Reply.
Topics: Anterior Chamber; Humans; Retinal Neoplasms; Retinoblastoma; Topotecan | 2018 |
Anterior Chamber Chemotherapy in Retinoblastoma-Necessary but Not Sufficient for Aqueous Seeding Control.
Topics: Anterior Chamber; Humans; Retinal Neoplasms; Retinoblastoma; Topotecan | 2018 |
Feasibility and results of an intraarterial chemotherapy program for the conservative treatment of retinoblastoma in Argentina.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Argentina; Carboplatin; Child; Child, Preschool; Conservative Treatment; Disease-Free Survival; Feasibility Studies; Female; Humans; Infusions, Intra-Arterial; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan; Young Adult | 2018 |
Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Electroretinography; Female; Follow-Up Studies; Humans; Infant; Infusions, Intra-Arterial; Male; Melphalan; Ophthalmic Artery; Retina; Retinal Detachment; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Survival Analysis; Topotecan; Treatment Outcome | 2018 |
Eye salvage in diffuse anterior retinoblastoma using systemic chemotherapy with periocular and intravitreal topotecan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Etoposide; Gonioscopy; Humans; Infant; Infusions, Intravenous; Intravitreal Injections; Male; Microscopy, Acoustic; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Topoisomerase I Inhibitors; Topotecan; Vincristine | 2018 |
Ophthalmic Vascular Events after Primary Unilateral Intra-arterial Chemotherapy for Retinoblastoma in Early and Recent Eras.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Female; Fluorescein Angiography; Humans; Infant; Infusions, Intra-Arterial; Male; Melphalan; Ophthalmoscopy; Retinal Diseases; Retinal Neoplasms; Retinal Vessels; Retinoblastoma; Retrospective Studies; Risk Factors; Topotecan; Ultrasonography; Young Adult | 2018 |
Folic acid-conjugated mesoporous silica nanoparticles for enhanced therapeutic efficacy of topotecan in retina cancers.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Shape; Endocytosis; Folic Acid; Humans; Nanoparticles; Porosity; Retinal Neoplasms; Silicon Dioxide; Topotecan; Treatment Outcome | 2018 |
Combined high-dose intra-arterial and intrathecal chemotherapy for the treatment of a case of extraocular retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child, Preschool; Humans; Infusions, Intra-Arterial; Injections, Spinal; Male; Melphalan; Retinal Neoplasms; Retinoblastoma; Topotecan | 2018 |
OPHTHALMIC VASCULAR EVENTS AFTER INTRA-ARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: Real-World Comparison Between Primary and Secondary Treatments.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Choroid; Female; Fluorescein Angiography; Humans; Infant; Infant, Newborn; Infusions, Intra-Arterial; Male; Melphalan; Ophthalmic Artery; Retinal Diseases; Retinal Neoplasms; Retinal Vessels; Retinoblastoma; Retrospective Studies; Topotecan; Young Adult | 2019 |
INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THE MANAGEMENT OF NEOVASCULARIZATION IN RETINOBLASTOMA AFTER INTRAVENOUS AND/OR INTRAARTERIAL CHEMOTHERAPY: Long-Term Outcomes in a Series of 35 Eyes.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Fluorescein Angiography; Humans; Infant; Infusions, Intra-Arterial; Infusions, Intravenous; Intravitreal Injections; Male; Melphalan; Microscopy, Acoustic; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Neoplasms; Retinal Neovascularization; Retinoblastoma; Retrospective Studies; Topotecan; Vascular Endothelial Growth Factor A | 2019 |
Intra-arterial chemotherapy for unilateral advanced intraocular retinoblastoma: Results and short-term complications.
Topics: Antineoplastic Agents; Child, Preschool; Eye; Female; Humans; Infant; Infusions, Intra-Arterial; Male; Melphalan; Meningeal Arteries; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan; Treatment Outcome | 2018 |
A three-dimensional organoid model recapitulates tumorigenic aspects and drug responses of advanced human retinoblastoma.
Topics: Antineoplastic Agents; Carcinogenesis; Child, Preschool; DNA Copy Number Variations; Gene Expression Regulation, Neoplastic; Humans; Infant; Melphalan; Models, Biological; Neoplasm Staging; Organoids; Retinal Neoplasms; Retinoblastoma; Topotecan | 2018 |
Commentary: Periocular topotecan for retinoblastoma.
Topics: Humans; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Topotecan | 2018 |
Periocular topotecan for vitreous seeds in retinoblastoma.
Topics: Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Injections, Intraocular; Male; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome; Visual Acuity; Vitreous Body | 2018 |
Association of electroretinography with visual outcomes after ophthalmic artery chemosurgery for retinoblastoma in ICRb D and E eyes.
Topics: Carboplatin; Case-Control Studies; Child; Child, Preschool; Electroretinography; Female; Humans; Infant; Infant, Newborn; Male; Melphalan; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan; Visual Acuity | 2019 |
Exudative Retinal Detachment Following Intravitreal Chemotherapeutic Treatment for Retinoblastoma.
Topics: Antineoplastic Agents, Alkylating; Child, Preschool; Drug Therapy, Combination; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Injections, Intraocular; Intravitreal Injections; Macula Lutea; Male; Melphalan; Retinal Detachment; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Topotecan; Triamcinolone Acetonide; Ultrasonography | 2019 |
Heterochromia following intravitreal chemotherapy in two cases.
Topics: Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Infant; Intravitreal Injections; Iris Diseases; Melphalan; Pigmentation Disorders; Retinal Neoplasms; Retinoblastoma; Tomography, Optical Coherence; Topotecan | 2019 |
Beyond retinocytomas: clinical benefit of topotecan in the management of other intra-cranial tumors especially glioblastomas.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Female; Humans; Inhibitor of Apoptosis Proteins; Male; Neoplasm Proteins; PTEN Phosphohydrolase; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Topotecan | 2013 |
No ocular motility complications after subtenon topotecan with fibrin sealant for retinoblastoma.
Topics: Child, Preschool; Combined Modality Therapy; Cross-Sectional Studies; Eye Enucleation; Eye Movement Measurements; Eye Movements; Fibrin Tissue Adhesive; Follow-Up Studies; Humans; Infant; Infant, Newborn; Injections; Ocular Motility Disorders; Postoperative Complications; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Tenon Capsule; Tissue Adhesives; Topoisomerase I Inhibitors; Topotecan; Treatment Failure | 2013 |
Clinical pharmacokinetics of intra-arterial melphalan and topotecan combination in patients with retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Humans; Infant; Infusions, Intra-Arterial; Male; Melphalan; Ophthalmic Artery; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Topotecan | 2014 |
Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year review.
Topics: Carboplatin; Electroretinography; Humans; Melphalan; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Topotecan; Treatment Outcome | 2014 |
Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Infant; Infusions, Intra-Arterial; International Classification of Diseases; Male; Melphalan; Microscopy, Acoustic; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan; Treatment Outcome; Young Adult | 2014 |
Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Female; Humans; Infant; Intravitreal Injections; Male; Melphalan; Neoplasm Seeding; Recurrence; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan; Vitreous Body | 2014 |
Choroidal thickness after intraarterial chemotherapy for retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Atrophy; Case-Control Studies; Child; Child, Preschool; Choroid; Female; Fluorescein Angiography; Humans; Infant; Infusions, Intra-Arterial; Male; Melphalan; Organ Size; Retinal Neoplasms; Retinoblastoma; Tomography, Optical Coherence; Topotecan | 2014 |
Is combination therapy for resistant vitreous seeds really essential?
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Melphalan; Neoplasm Seeding; Retinal Neoplasms; Topotecan; Vitreous Body | 2015 |
Is combination therapy for resistant vitreous seeds really essential? - reply.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Melphalan; Neoplasm Seeding; Retinal Neoplasms; Topotecan; Vitreous Body | 2015 |
Enophthalmos and choroidal atrophy after intraophthalmic artery chemotherapy for retinoblastoma.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Chemotherapy, Cancer, Regional Perfusion; Choroid; Choroid Diseases; Combined Modality Therapy; Diseases in Twins; Enophthalmos; Female; Fluorescein Angiography; Humans; Infant; Laser Coagulation; Magnetic Resonance Imaging; Melphalan; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Scleritis; Topoisomerase I Inhibitors; Topotecan; Twins, Monozygotic | 2015 |
Using cost-effective intra-arterial chemotherapy to treat retinoblastoma in Chile.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chile; Cost-Benefit Analysis; Developing Countries; Drug Costs; Humans; Infant; Infusions, Intra-Arterial; Male; Melphalan; Retinal Neoplasms; Retinoblastoma; Topotecan | 2014 |
Intravitreal chemotherapy provides control for massive vitreous seeding from retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Eye Neoplasms; Female; Humans; Intravitreal Injections; Melphalan; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Topotecan; Vitreous Body | 2014 |
Hypersensitivity to sub-Tenon's topotecan in fibrin adhesive in patients with retinoblastoma.
Topics: Anti-Allergic Agents; Antineoplastic Agents; Child, Preschool; Conjunctival Diseases; Diphenhydramine; Drug Carriers; Drug Hypersensitivity; Edema; Eye Enucleation; Eyelid Diseases; Female; Fibrin Tissue Adhesive; Humans; Male; Retinal Neoplasms; Retinoblastoma; Tenon Capsule; Topoisomerase I Inhibitors; Topotecan; Urticaria | 2015 |
Spectral Domain Optical Coherence Tomography Reveals Hidden Fovea Beneath Extensive Vitreous Seeding From Retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Eye Neoplasms; Female; Fovea Centralis; Humans; Infusions, Intra-Arterial; Intravitreal Injections; Melphalan; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Tomography, Optical Coherence; Topotecan; Vitreous Body | 2015 |
Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child, Preschool; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Infusions, Intra-Arterial; Male; Melphalan; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retinoscopy; Retreatment; Salvage Therapy; Topotecan; Treatment Failure; Treatment Outcome | 2015 |
Intra-arterial chemotherapy for retinoblastoma: First Indian report.
Topics: Antineoplastic Agents; Carboplatin; Child, Preschool; Dose-Response Relationship, Drug; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Incidence; India; Infant; Injections, Intra-Arterial; Male; Melphalan; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Time Factors; Topoisomerase I Inhibitors; Topotecan | 2015 |
Identification of Intraorbital Arteries in Pediatric Age by High Resolution Superselective Angiography.
Topics: Angiography, Digital Subtraction; Antineoplastic Combined Chemotherapy Protocols; Carotid Artery, Internal; Child, Preschool; Humans; Infusions, Intra-Arterial; Melphalan; Ophthalmic Artery; Orbit; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan | 2015 |
Alternated intra-arterial and intravitreal chemotherapy for advanced intraocular retinoblastoma: preliminary successful results without systemic chemotherapy.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Female; Humans; Infant; Injections, Intra-Arterial; Intravitreal Injections; Male; Melphalan; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan | 2015 |
Selective Ophthalmic Artery Infusion Chemotherapy for Advanced Intraocular Retinoblastoma: CCHMC Early Experience.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intra-Arterial; Male; Melphalan; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan | 2016 |
INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Eye Neoplasms; Female; Follow-Up Studies; Humans; Infant; Intravitreal Injections; Male; Melphalan; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan; Vitreous Body | 2016 |
Chemoreduction of Progressive Intraocular Retinoblastoma by Systemic Topotecan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Child, Preschool; Eye Enucleation; Female; Follow-Up Studies; Humans; Infant; Male; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Topoisomerase I Inhibitors; Topotecan | 2016 |
Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy).
Topics: Carboplatin; Child; Child, Preschool; Electroretinography; Female; Humans; Kaplan-Meier Estimate; Male; Melphalan; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan | 2016 |
Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.
Topics: Antineoplastic Agents; Carboplatin; Child, Preschool; Female; Humans; Infant; Male; Melphalan; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan | 2016 |
Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Topics: Antineoplastic Agents, Alkylating; Child; Child, Preschool; Eye Enucleation; Female; Humans; Infant; Infusions, Intra-Arterial; Intravitreal Injections; Male; Melphalan; Neoplasm Seeding; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topoisomerase I Inhibitors; Topotecan | 2016 |
Intra-arterial Chemotherapy for Adult Onset Retinoblastoma in a 32-Year-Old Man.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Combined Modality Therapy; Humans; Infusions, Intra-Arterial; Male; Melphalan; Neoplasm Recurrence, Local; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Topotecan; Ultrasonography; Visual Acuity; Vitreous Body | 2016 |
Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cohort Studies; Disease-Free Survival; Electroretinography; Female; Humans; Infant; Injections, Intraocular; Intravitreal Injections; Male; Melphalan; Neoplasm Seeding; Ophthalmic Artery; Ophthalmoscopy; Retina; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome; Vitreous Body | 2017 |
Intraocular Pressure Changes Following Intravitreal Melphalan and Topotecan for the Treatment of Retinoblastoma With Vitreous Seeding.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Intravitreal Injections; Male; Melphalan; Neoplasm Seeding; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome; Vitreous Body; Young Adult | 2017 |
Diagnosis and management of secondary epipapillary retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Child, Preschool; Cryotherapy; Female; Humans; Hyperthermia, Induced; Infant; Infusions, Intra-Arterial; Male; Melphalan; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Tomography, Optical Coherence; Topotecan | 2017 |
White orbital mass after enucleation for retinoblastoma: The power of illusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Catgut; Eye Enucleation; Fluorescein Angiography; Foreign-Body Reaction; Granuloma, Foreign-Body; Humans; Infant; Intravitreal Injections; Magnetic Resonance Imaging; Male; Melphalan; Neoplasm Staging; Orbital Diseases; Orbital Implants; Retinal Neoplasms; Retinoblastoma; Suture Techniques; Topotecan | 2017 |
Trilateral retinoblastoma with pituitary-hypothalamic dysfunction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Etoposide; Fatal Outcome; Female; Gestational Age; Humans; Hypothalamic Diseases; Infant; Infusions, Parenteral; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pituitary Neoplasms; Retinal Neoplasms; Retinoblastoma; Retinoblastoma Protein; Tomography, X-Ray Computed; Topotecan; Vincristine | 2008 |
Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Caspases; Cell Survival; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; MicroRNAs; Piperazines; Retinal Neoplasms; Retinoblastoma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Topotecan; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2009 |
Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Electroretinography; Evoked Potentials, Visual; Female; Follow-Up Studies; Functional Laterality; Humans; Infant; Infusions, Intra-Arterial; Male; Melphalan; Ophthalmic Artery; Retina; Retinal Neoplasms; Retinoblastoma; Topotecan; Treatment Outcome | 2010 |
Pharmacokinetic analysis of topotecan after intra-vitreal injection. Implications for retinoblastoma treatment.
Topics: Animals; Antineoplastic Agents; Aqueous Humor; Biological Availability; Chromatography, High Pressure Liquid; Injections; Rabbits; Retinal Neoplasms; Retinoblastoma; Topotecan; Vitreous Body | 2010 |
Subconjunctival carboplatin and systemic topotecan treatment in preclinical models of retinoblastoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Line, Tumor; Conjunctiva; Disease Models, Animal; Humans; Mice; Mice, Inbred C57BL; Rats; Retinal Neoplasms; Retinoblastoma; Topotecan; Visual Acuity; Xenograft Model Antitumor Assays | 2011 |
Multifaceted chemotherapy for trilateral retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cyclosporine; Cytarabine; Etoposide; Fatal Outcome; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pineal Gland; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Topotecan; Vincristine | 2011 |
Periocular topotecan for intraocular retinoblastoma.
Topics: Child, Preschool; Follow-Up Studies; Humans; Infant; Infant, Newborn; Injections; Orbit; Retina; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome | 2011 |
Success of intra-arterial chemotherapy (chemosurgery) for retinoblastoma: effect of orbitovascular anatomy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blood Flow Velocity; Carboplatin; Child; Child, Preschool; Female; Fluorescein Angiography; Humans; Infant; Infusions, Intra-Arterial; Male; Melphalan; Ophthalmic Artery; Orbit; Regional Blood Flow; Retinal Neoplasms; Retinoblastoma; Topotecan; Young Adult | 2012 |
Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Disease-Free Survival; Eye; Follow-Up Studies; Humans; Infant; Melphalan; Ophthalmic Artery; Ophthalmologic Surgical Procedures; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topotecan; Young Adult | 2012 |
Topotecan vitreous and plasma levels and retinal toxicity after transcorneal intravitreal delivery in healthy albino rabbits: alternative retinoblastoma treatment.
Topics: Animals; Rabbits; Retina; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Topotecan; Vitreous Body | 2012 |
Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Infusions, Intra-Arterial; Male; Melphalan; Middle Aged; Pilot Projects; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome; Young Adult | 2012 |
Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
Topics: Administration, Intravenous; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Injections, Intra-Arterial; Injections, Intraocular; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Salvage Therapy; Topotecan; Treatment Outcome; Vincristine; Young Adult | 2013 |
Effect of topotecan on retinocytoma cell apoptosis and expression of Livin and PTEN.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Cell Line, Tumor; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Inhibitor of Apoptosis Proteins; Male; Neoplasm Proteins; PTEN Phosphohydrolase; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Topotecan | 2013 |
Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Topics: Animals; Drug Administration Schedule; Electroretinography; Intravitreal Injections; Models, Biological; Nonlinear Dynamics; Ophthalmoscopy; Rabbits; Retina; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Topotecan; Vitreous Body | 2013 |
Activity of topotecan in retinoblastoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Topoisomerase I Inhibitors; Topotecan | 2004 |
Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
Topics: Animals; Animals, Newborn; Antineoplastic Agents; Apoptosis; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Etoposide; Eye; Humans; Mice; Mice, Knockout; Rats; Retinal Neoplasms; Retinoblastoma; Time Factors; Topotecan; Vincristine; Xenograft Model Antitumor Assays | 2005 |
Topotecan vitreous levels after periocular or intravenous delivery in rabbits: an alternative for retinoblastoma chemotherapy.
Topics: Animals; Antineoplastic Agents; Blood-Retinal Barrier; Infusions, Intravenous; Injections; Models, Biological; Rabbits; Retinal Neoplasms; Retinoblastoma; Topotecan; Vitreous Body | 2007 |
Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Topics: Animals; Antigens, Polyomavirus Transforming; Antineoplastic Agents; Apoptosis; Cell Cycle; Conjunctiva; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Enzyme Inhibitors; Fibrin Tissue Adhesive; Injections; Luteinizing Hormone; Mice; Mice, Transgenic; Retinal Neoplasms; Retinoblastoma; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured | 2008 |